AKBA
Price:
$1.07
Market Cap:
$287.04M
Akebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for patients suffering from kidney diseases. The firm's leading experimental drug, vadadustat, is an oral treatment currently in Phase III clinical trials. Its purpose is to address anemia resulting from chronic kidney disease (CKD) in adult patients, encompassing both those dependent on dialysis and those who are not. Akebia also markets Auryxia, a ferric citrate product used to manage serum phosphorus levels in adult CKD patients undergoing dialysis, and to treat iron deficiency anemia in adult CKD patients who are...[Read more]
Industry
Biotechnology
IPO Date
2014-03-20
Stock Exchange
NASDAQ
Ticker
AKBA
According to Akebia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Akebia Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), AKBA's Dividend Yield was at its highest in in the June 2016 quarter at 0%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Akebia Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
The current Dividend Yield of Akebia Therapeutics, Inc. (AKBA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Akebia Therapeutics, Inc.’s Dividend Yield is less than Corvus Pharmaceuticals, Inc. (0%), less than Prothena Corporation plc (0%), less than Olema Pharmaceuticals, Inc. (0%), less than Gossamer Bio, Inc. (0%), less than Rigel Pharmaceuticals, Inc. (0%), less than KalVista Pharmaceuticals, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than Compass Therapeutics, Inc. (0%), less than 4D Molecular Therapeutics, Inc. (0%), less than Zevra Therapeutics, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $1.00B | |
| 0% | $467.51M | |
| 0% | $830.67M | |
| 0% | $39.40M | |
| 0% | $608.90M | |
| 0% | $1.44B | |
| 0% | $1.00B | |
| 0% | $279.34M | |
| 0% | $504.99M | |
| 0% | $762.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akebia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Akebia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Akebia Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Akebia Therapeutics, Inc. (AKBA)?
What is the highest Dividend Yield for Akebia Therapeutics, Inc. (AKBA)?
What is the 3-year average Dividend Yield for Akebia Therapeutics, Inc. (AKBA)?
What is the 5-year average Dividend Yield for Akebia Therapeutics, Inc. (AKBA)?
How does the current Dividend Yield for Akebia Therapeutics, Inc. (AKBA) compare to its historical average?